Results 241 to 250 of about 252,165 (283)

First-line treatment for CLL in the era of targeted therapy. [PDF]

Blood Cancer J
Davids MS, Stilgenbauer S, Tam CS.
europepmc   +1 more source

Triplet regimens for frontline treatment of CLL-Great company or just a crowd? [PDF]

Hemasphere
McKeague S, Seymour JF.
europepmc   +1 more source

A comparative health economic evaluation of venetoclax in combination with obinutuzumab versus Chlorambucil in combination with obinutuzumab as first-line treatment for chronic lymphocytic leukemia in China: a cost-effectiveness analysis. [PDF]

Cost Eff Resour Alloc
Du J, Ran H, Zheng Z, Yu X, Feng T.
europepmc   +1 more source

Defective cell-autonomous signalling and antigenic polyreactivity of B-cell receptors from chronic lymphocytic leukaemia stereotyped subset 1. [PDF]

Nat Commun
Cocomazzi PG, Iatrou A, Minici C, Gounari M, Linder AT, Akpınaroğlu C, Patrone M, Broggini L, Frenquelli M, Sarrigeorgiou I, Lymberi P, Petrakis G, Koletsa T, Scarfò L, Agathangelidis A, Jumaa H, Maity PC, Ghia P, Stamatopoulos K, Degano M.   +19 more
europepmc   +1 more source

Monoclonal gammopathy defines distinct clinical subsets in chronic lymphocytic leukemia across therapeutic eras. [PDF]

Blood Adv
Yan Y, Yuan B, Qiu T, Liu G, Chen W, Wang T, Yu Y, Xiong W, An G, Zou D, Li J, Wang L, Yi S.   +12 more
europepmc   +1 more source

Avaliação do perfil hematológico de pacientes com leucemia linfocítica crônica (LLC-B) em um hemocentro estadual Evaluation of the hematologic profile of patients with chronic lymphocytic leukemia (CLL-B) at a state hemocenter

, 2009
Romélia Pinheiro Gonçalves, Daniel P. Maia, Richeyla K. A. Custódio, Rosângela Pinheiro Gonçalves Machado, Fernando Barroso Duarte, Lilianne B. Silva   +5 more
openalex   +1 more source

Global burden of leukemia in women of child-bearing age, 1990 to 2021: An update from the Global Burden of Disease Study 2021. [PDF]

Medicine (Baltimore)
Chen XB, Yang ZH, Ling WJ, Feng QJ, Lu ZY.   +4 more
europepmc   +1 more source

Patterns of Bruton's Tyrosine Kinase Inhibitor (BTKi) Usage in B-cell Lymphomas in India: A Questionnaire-Based Study. [PDF]

Cureus
Naseem A, Pednekar A, Patil S, Barkate H.   +3 more
europepmc   +1 more source

The Development of Novel Therapies for Chronic Lymphocytic Leukaemia in the Era of Targeted Drugs. [PDF]

J Clin Med
Robak T, Iskierka-Jażdżewska E, Puła A, Robak P, Puła B.   +4 more
europepmc   +1 more source